Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HANOVER INSURANCE GROUP, INC.THG · Entity 3652 | Director · President & CEO | February 24, 2017 | February 28, 2017 |
| MOLINA HEALTHCARE, INC.MOH · Entity 3504 | Director · President & CEO | March 01, 2026 | March 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HANOVER INSURANCE GROUP, INC.
Report date February 24, 2017 · Filed February 28, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $91.19 · Expires 2027-02-24 | Direct | 114,165 |
Reported balance
After 2017-02-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-02-24 · Grant · Acquired 114,165 · Balance 114,165 F1: Such options vest as to one-third of the shares on each of the first three anniversaries of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Such options vest as to one-third of the shares on each of the first three anniversaries of the grant date.
MOLINA HEALTHCARE, INC.
Report date March 01, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 32,598 |
Reported balance
After 2026-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-01 · Tax withholding · Disposed 8,597 · Balance 32,598 F1: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 20,623 shares on March 1, 2026. F2: Represents the closing price of the Issuer's common stock on February 27, 2026. |
| Common StockSEC Table I · non-derivative | Direct | 99,015 |
Reported balance
After 2026-03-01 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-03-01 · Grant · Acquired 66,417 · Balance 99,015 F3: Grant of restricted stock under the Issuer's 2025 Equity Incentive Plan. F4: Represents the volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2026 grant date. F5: The shares shall vest as follows: The 66,417 newly granted shares shall vest in one-third increments on each of March 1, 2027, March 1, 2028, and March 1, 2029. Additional shares shall vest as follows: 13,075 shares on March 1, 2027; and 7,497 shares on March 1, 2028. The remaining shares are vested. |
| Common StockSEC Table I · non-derivative | IndirectHeld by Trust | 257,715 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 257,715 F6: Shares are held by Joseph M. Zubretsky Revocable Trust, of which Joseph M. Zubretsky is the sole trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 20,623 shares on March 1, 2026.
F2: Represents the closing price of the Issuer's common stock on February 27, 2026.
F3: Grant of restricted stock under the Issuer's 2025 Equity Incentive Plan.
F4: Represents the volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2026 grant date.
F5: The shares shall vest as follows: The 66,417 newly granted shares shall vest in one-third increments on each of March 1, 2027, March 1, 2028, and March 1, 2029. Additional shares shall vest as follows: 13,075 shares on March 1, 2027; and 7,497 shares on March 1, 2028. The remaining shares are vested.
F6: Shares are held by Joseph M. Zubretsky Revocable Trust, of which Joseph M. Zubretsky is the sole trustee.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 21, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 3,013 | $340.14 | $1,024,831.27 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 28 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,757 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F26 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $339.74 to $340.72. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 2,752 | $339.23 | $933,563.16 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 27 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,770 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F25 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $338.74 to $339.73. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 4,881 | $338.25 | $1,651,006.06 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 26 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,522 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F24 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $337.73 to $338.72. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 3,754 | $337.26 | $1,266,068.78 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 25 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,403 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F23 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $336.73 to $337.72. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 4,079 | $336.18 | $1,371,268.43 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 24 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,157 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F22 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $335.70 to $336.69. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 2,262 | $335.20 | $758,214.94 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 23 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,236 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F21 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $334.68 to $335.66. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 1,497 | $334.22 | $500,331.68 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 22 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,498 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F20 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $333.68 to $334.67. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 1,369 | $332.89 | $455,728.05 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 21 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,995 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F19 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $332.66 to $332.61. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 3,669 | $332.22 | $1,218,897.94 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 20 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,364 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F18 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $331.66 to $332.63. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionCommon Stock | 27,876 | $67.33 | $1,876,891.08 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 19 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $67.33 | $0.00 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · derivative · entry 31 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,000 Underlying: Common Stock · 30,000 shares Expires 2027-10-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F29 · derivative.exercise_date: The options are fully vested. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 216 | $342.00 | $73,872.00 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 18 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,157 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F17 · price: Represents the actual selling price per share of all 216 shares. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 100 | $340.96 | $34,096.00 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 17 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,373 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F16 · price: Represents the actual selling price per share of all 100 shares. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 1,213 | $340.21 | $412,676.55 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 16 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,473 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F15 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $339.92 to $340.91. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 5,573 | $339.30 | $1,890,904.41 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 15 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,686 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F14 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $338.92 to $339.91. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 14,690 | $338.35 | $4,970,326.24 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 14 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,259 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F13 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $337.92 to $338.91. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 6,712 | $337.59 | $2,265,889.31 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 13 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,949 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F12 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $336.92 to $337.91. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 1,496 | $336.55 | $503,475.66 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 12 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,661 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F11 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $335.84 to 336.77. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionCommon Stock | 30,000 | $67.33 | $2,019,900.00 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 11 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. Read SEC document |
| September 19, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $67.33 | $0.00 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · derivative · entry 30 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,000 Underlying: Common Stock · 30,000 shares Expires 2027-10-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F29 · derivative.exercise_date: The options are fully vested. Read SEC document |
| September 19, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 600 | $341.05 | $204,631.98 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 29 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,157 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F27 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $340.92 to $341.37. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. F28 · balance_after: 30,372 shares vest on March 1, 2023; 15,412 shares vest on March 1, 2024; 6,412 shares vest on March 1, 2025. The remainder of the shares are vested. Read SEC document |
| September 19, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 4,173 | $344.06 | $1,435,759.46 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 10 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,157 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F10 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $343.58 to $344.56. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 19, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 1,393 | $343.01 | $477,809.59 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 9 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,330 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F9 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $342.31 to $343.30. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 19, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 8,651 | $341.59 | $2,955,062.22 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 8 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,723 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F8 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $341.18 to $342.08. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 19, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 7,206 | $340.80 | $2,455,831.46 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 7 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,374 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F7 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $340.18 to $341.17. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 19, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 3,155 | $339.73 | $1,071,857.62 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 6 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,580 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F6 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $339.17 to $340.16. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 19, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 700 | $338.34 | $236,838.63 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 5 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,735 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F5 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $337.96 to $338.78. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 19, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 1,703 | $337.34 | $574,492.40 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 4 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,435 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F4 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $336.80 to $337.69. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 19, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 2,249 | $336.24 | $756,193.64 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 3 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,138 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $335.80 to $336.78. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 19, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 770 | $335.15 | $258,062.11 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 2 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,387 F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $334.70 to $335.68. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| September 19, 2022 Filed Sep 22, 2022 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionCommon Stock | 30,000 | $67.33 | $2,019,900.00 |
DisclosureSEC source: 0001179929-22-000141 · wf-form4_166380565436537.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: As was previously reported in the Company's Form 8-K Current Report filed on August 17, 2022, all options were exercised and shares sold pursuant to Mr. Zubretsky's Rule 10b5-1 trading plan. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 00:57 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GiftCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179929-22-000048 · wf-form4_164678744764127.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,157 F1 · kind: Reflects the gift of common stock to a charitable donor advised fund. F2 · price: Price not applicable to gift. F3 · balance_after: The shares shall vest as follows: 30,372 shares on March 1, 2023; 15,412 shares on March 1, 2024; 6,412 shares on March 1, 2025. The remainder of the shares are vested. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:30 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Tax withholdingCommon Stock | 55,157 | $311.88 | $17,202,365.16 |
DisclosureSEC source: 0001179929-22-000040 · wf-form4_164635742182823.xml · nonDerivative · entry 4 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,757 F5 · kind: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. F6 · balance_after: The shares shall vest as follows: the 19,238 newly granted shares vest in one-third increments on each of March 1, 2023, March 1, 2024, and March 1, 2025. Additional shares shall vest as follows: 23,959 shares on March 1, 2023 and 8,999 on March 1, 2024. The remaining shares are vested. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:30 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 112,718 | $311.88 | $35,154,489.84 |
DisclosureSEC source: 0001179929-22-000040 · wf-form4_164635742182823.xml · nonDerivative · entry 3 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,914 F4 · kind: Shares issued in settlement of performance stock units granted in 2019 which vested at the 200% max level based on the achievement of cumulative net income metric over the three fiscal years of 2019, 2020 and 2021. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:30 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Tax withholdingCommon Stock | 17,704 | $311.88 | $5,521,523.52 |
DisclosureSEC source: 0001179929-22-000040 · wf-form4_164635742182823.xml · nonDerivative · entry 2 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,196 F3 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 36,484 shares on March 1, 2022. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:30 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 19,238 | $311.88 | $5,999,947.44 |
DisclosureSEC source: 0001179929-22-000040 · wf-form4_164635742182823.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,900 F1 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2022. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:43 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Tax withholdingCommon Stock | 86,084 | $222.24 | $19,131,308.16 |
DisclosureSEC source: 0001179929-21-000046 · wf-form4_161482221971648.xml · nonDerivative · entry 4 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,662 F5 · kind: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2021. F6 · balance_after: The shares shall vest as follows: the 26,998 newly granted shares vest in one-third increments on each of March 1, 2022, March 1, 2023, and March 1, 2024. Additional shares shall vest as follows: 27,484 shares on March 1, 2022 and 14,960 shares on March 1, 2023. The remaining shares are vested. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:43 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 166,944 | $222.24 | $37,101,634.56 |
DisclosureSEC source: 0001179929-21-000046 · wf-form4_161482221971648.xml · nonDerivative · entry 3 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,746 F4 · kind: Shares issued in settlement of performance stock units granted in 2018 which vested at the 200% max level based on the achievement of cumulative net income metric over the three fiscal years of 2018, 2019, and 2020. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2021. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:43 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Tax withholdingCommon Stock | 24,057 | $222.24 | $5,346,427.68 |
DisclosureSEC source: 0001179929-21-000046 · wf-form4_161482221971648.xml · nonDerivative · entry 2 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,802 F3 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 46,033 shares on March 1, 2021. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2021. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:43 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 26,998 | $222.24 | $6,000,035.52 |
DisclosureSEC source: 0001179929-21-000046 · wf-form4_161482221971648.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,859 F1 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2021. Read SEC document |
| March 01, 2020 Filed Mar 4, 2020 00:48 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 44,880 | $122.55 | $5,500,044.00 |
DisclosureSEC source: 0001179929-20-000040 · wf-form4_158328286329056.xml · nonDerivative · entry 2 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,861 F3 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan. F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2020. F4 · balance_after: The shares shall vest as follows: the 44,880 newly granted shares vest in one-third increments on each of March 1, 2021, March 1, 2022, and March 1, 2023; 31,073 shares on March 1, 2021, and 12,524 shares on March 1, 2022. The remaining shares are vested. Read SEC document |
| March 01, 2020 Filed Mar 4, 2020 00:48 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Tax withholdingCommon Stock | 15,401 | $122.55 | $1,887,392.55 |
DisclosureSEC source: 0001179929-20-000040 · wf-form4_158328286329056.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,981 F1 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 31,073 shares on March 1, 2020. F2 · price: Represents the closing price of the Issuer's common stock on February 28, 2020. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 01:38 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Tax withholdingCommon Stock | 8,838 | $138.40 | $1,223,179.20 |
DisclosureSEC source: 0001179929-19-000052 · wf-form4_155183631169896.xml · nonDerivative · entry 2 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,382 F3 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 18,550 shares on March 1, 2019. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2019. F4 · balance_after: The 37,572 newly granted shares shall vest in one-third increments on each of March 1, 2020, March 1, 2021, and March 1, 2022; 18,549 shares vest on each of March 1, 2020, and March 1, 2021. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 01:38 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 37,572 | $138.40 | $5,199,964.80 |
DisclosureSEC source: 0001179929-19-000052 · wf-form4_155183631169896.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,220 F1 · kind: Grant of restricted stock under the Issuer's 2011 Equity Incentive Plan, as amended. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2019. Read SEC document |
| March 01, 2018 Filed Mar 3, 2018 02:24 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 55,648 | $71.88 | $3,999,978.24 |
DisclosureSEC source: 0001179929-18-000051 · wf-form4_152004387116098.xml · nonDerivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,648 F1 · kind: Grant of restricted stock under the Issuer's 2011 Equity Incentive Plan, as amended. F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2018. F3 · balance_after: The 55,648 newly granted shares vest in one-third increments on each of March 1, 2019, March 1, 2020, and March 1, 2021. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 22:08 UTC | HANOVER INSURANCE GROUP, INC. THG · Entity 3652 | GrantCommon Stock Option (right to buy) · Derivative | 114,165 | $0.00 Strike: $91.19 | $0.00 |
DisclosureSEC source: 0000944695-17-000036 · edgar.xml · derivative · entry 1 Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,165 Underlying: Common Stock · 114,165 shares Expires 2027-02-24 F1 · derivative.exercise_date: Such options vest as to one-third of the shares on each of the first three anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.